IFN-γ, which is a main effector factor of Group 1 innate lymphocytes, inhibits the proliferation and angiogenesis of tumor cells and enhances the cytotoxic activity of CTLs to promote antitumor effects [11, 12]. Here, IFNG is linked to neoplasm.